Top

Published in:

01-08-2014 | Epidemiology

Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study

Authors: Stephanie M. George, Leslie Bernstein, Ashley W. Smith, Marian L. Neuhouser, Kathy B. Baumgartner, Richard N. Baumgartner, Rachel Ballard-Barbash

Published in: Breast Cancer Research and Treatment | Issue 3/2014

Abstract

We examined whether waist circumference (WC) and waist-to-hip ratio (WHR) after breast cancer diagnosis are associated with all-cause or breast cancer-specific mortality and explored potential biological pathways mediating these relationships. Our analysis included 621 women diagnosed with local or regional breast cancer who participated in the Health, Eating, Activity, and Lifestyle study. At 30 (±4) months postdiagnosis, trained staff measured participants’ waist and hip circumferences and obtained fasting serum samples for biomarker assays for assays of insulin, glucose, C-peptide, insulin growth factor-1 and binding protein-3, C-reactive protein (CRP), and adiponectin. We estimated multivariate hazard ratios (HR) and 95 % confidence intervals (CI) for death over ~9.5 years of follow-up. After adjustment for measured body mass index, treatment, comorbidities, race/ethnicity, diet quality, and postdiagnosis physical activity, WC was positively associated with all-cause mortality (HR_q4:q1: 2.99, 95 % CI 1.14, 7.86) but its positive association with breast cancer-specific mortality was not statistically significant (HR_q4:q1: 2.69, 95 % CI 0.69, 12.01). WHR was positively associated with all-cause mortality (HR_q4:q1: 2.10, 95 % CI 1.08, 4.05) and breast cancer-specific mortality (HR_q4:q1: 4.02, 95 % CI 1.31, 12.31). After adjustment for homeostatic model assessment (HOMA) score and C-reactive protein, risk estimates were attenuated and not statistically significant. In this diverse breast cancer survivor cohort, postdiagnosis WC and WHR were associated with all-cause mortality. Insulin resistance and inflammation may mediate the effects of central adiposity on mortality among breast cancer patients.

American Cancer Society (2014) Cancer facts & figures 2014. American Cancer Society, Atlanta

Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W et al (eds) (2010) SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda

American Cancer Society (2009) Breast cancer facts and figures 2009–2010. American Cancer Society, Atlanta

Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt J et al (2012) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev 21(8):1244–1259. doi:10.1158/1055-9965.epi-12-0485 CrossRef

Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A et al (2014) Body mass index and survival in women with breast cancer–systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. doi:10.1093/annonc/mdu042

Snijder M, van Dam R, Visser M, Seidell J (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35(1):83–92. doi:10.1093/ije/dyi253 PubMedCrossRef

World Health Organization (2008) Waist circumference and waist–hip ratio. Report of a WHO expert consultation. World Health Organization, Geneva

Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO et al (2014) A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc 89(3):335–345. doi:10.1016/j.mayocp.2013.11.011 PubMedCrossRef

Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K et al (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36(9):1484–1491PubMedCentralPubMed

10.

McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R et al (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21(10):1961–1966. doi:10.1200/JCO.2003.07.057 PubMedCentralPubMedCrossRef

11.

Wayne SJ, Baumgartner K, Baumgartner RN, Bernstein L, Bowen DJ, Ballard-Barbash R (2006) Diet quality is directly associated with quality of life in breast cancer survivors. Breast Cancer Res Treat 96(3):227–232PubMedCrossRef

12.

Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160(7):953–958PubMedCrossRef

13.

Lohman T, Roche A, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics, Champaign

14.

Kriska A (1997) Modifiable activity questionnaire. Med Sci Sports Exerc 29(6):73–78

15.

Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD et al (2008) Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 26(24):3958–3964. doi:10.1200/jco.2007.15.9822 PubMedCentralPubMedCrossRef

16.

Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T (1999) Measurement characteristics of the women’s health initiative food frequency questionnaire. Ann Epidemiol 9(3):178–187PubMedCrossRef

17.

Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124(3):453–469PubMed

18.

Guenther PM, Krebs-Smith SM, Reedy J, Britten P, Juan W, Lino M et al (2008) Healthy Eating Index-2005. United States Department of Agriculture, Center for Nutrition Policy and Promotion, Beltsville

19.

Guenther PM, Reedy J, Krebs-Smith SM (2008) Development of the Healthy Eating Index-2005. J Am Diet Assoc 108(11):1896–1901. doi:10.1016/j.jada.2008.08.016 PubMedCrossRef

20.

Guenther PM, Reedy J, Krebs-Smith SM, Reeve BB (2008) Evaluation of the Healthy Eating Index-2005. J Am Diet Assoc 108(11):1854–1864. doi:10.1016/j.jada.2008.08.011 PubMedCrossRef

21.

Guenther PM, Reedy J, Krebs-Smith SM, Reeve BB, Basiotis PP (2007) Development and evaluation of the healthy eating index-2005: technical report: center for nutrition policy and promotion. U.S Department of Agriculture, Alexandria

22.

U.S. Department of Health and Human Services and U.S. Department of Agriculture (2005) Dietary guidelines for Americans, 6th edn. U.S. Government Printing Office, Washington, DC

23.

George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A et al (2011) Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control 22(4):589–598. doi:10.1007/s10552-011-9732-9 PubMedCentralPubMedCrossRef

24.

Schakel SF, Buzzard IM, Gebhardt SE (1997) Procedures for estimating nutrient values for food composition databases. J Food Compos Anal 10:102–114CrossRef

25.

Schakel SF, Sievert YA, Buzzard IM (1988) Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 88(10):1268–1271PubMed

26.

MyPyramid Equivalents Database, 2.0 for USDA Survey Foods, 2003–2004 [database on the Internet] (2008). Food Surveys Research Group. Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD. http://www.ars.usda.gov/ba/bhnrc/fsrg. Accessed 1 May 2014

27.

Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N (1998) Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 35(Pt 6):745–753PubMedCrossRef

28.

Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, Baumgartner RN et al (2011) Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol 29(1):47–53. doi:10.1200/JCO.2010.28.4752 PubMedCentralPubMedCrossRef

29.

Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN et al (2011) Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29(1):32–39. doi:10.1200/JCO.2009.26.4473 PubMedCentralPubMedCrossRef

30.

Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW et al (2013) Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer 132(5):1191–1200. doi:10.1002/ijc.27753 PubMedCentralPubMedCrossRef

31.

Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437–3444. doi:10.1200/jco.2008.18.9068 PubMedCentralPubMedCrossRef

32.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404 PubMedCrossRef

33.

Villaseñor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML (2012) Prevalence and prognostic effect of sarcopenia in breast cancer survivors; the HEAL Study. Journal of Cancer Survivorship: Research and Practice 6:398–406CrossRef

34.

Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I et al (2014) Obesity and mortality after breast cancer by race/ethnicity: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 179(1):95–111. doi:10.1093/aje/kwt233 PubMedCrossRef

35.

Tao MH, Shu XO, Ruan ZX, Gao YT, Zheng W (2006) Association of overweight with breast cancer survival. Am J Epidemiol 163(2):101–107. doi:10.1093/aje/kwj017 PubMedCrossRef

36.

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359(20):2105–2120. doi:10.1056/NEJMoa0801891 PubMedCrossRef

Title: Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study
Authors: Stephanie M. George
Leslie Bernstein
Ashley W. Smith
Marian L. Neuhouser
Kathy B. Baumgartner
Richard N. Baumgartner
Rachel Ballard-Barbash
Publication date: 01-08-2014
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-014-3048-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases

Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia

Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States

ERβ splice variant expression in four large cohorts of human breast cancer patient tumors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer